+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Pharmaceutical Isolators Market (High-value & Low-value): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

  • PDF Icon

    Report

  • 87 Pages
  • July 2022
  • Region: Global
  • Koncept Analytics
  • ID: 5622566
UP TO OFF until Dec 31st 2022
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The global pharmaceutical isolators market is expected to record a value of US$2.42 billion in 2026, growing at a CAGR of 11.25%, for the time period of 2022-2026. Factors such as expansion of biotechnology industry, explosive growth of cell & gene therapies in development, increasing use of high potency active pharmaceutical ingredients, rising focus on contract development manufacturing organizations (CDMOs) and regulatory framework to support adoption of pharmaceutical isolators are likely to drive the market growth. However, the growth of the market would be challenged by issues in the maintenance of pharmaceutical isolators. A few notable trends may include growing share of isolators in aseptic manufacturing market, upsurge in pharmaceutical R&D spending and automation inside isolators.



Based on tier, the global isolator market has been segmented into High-value Isolators and Low-value Isolators. Among them, the share of high-value isolators is significantly growing due to the presence of standard quality in providing sterile environment. Within the segment, premium high-value isolators are gaining high popularity due their increasing adoption by CDMOs (Contract Development Manufacturing Organizations).

The fastest growing regional market is the U.S. due to the rising development of new drugs, generic medicines, and biosimilars. Europe and Asia Pacific also held significant shares in the market, owing to the rise in investment by large pharmaceutical companies on new product launches and growth in the MA& deals among the biopharmaceutical firms.

Scope of the report

  • The report provides a comprehensive analysis of the global pharmaceutical isolators market.
  • The major regions (the U.S., Europe, Asia Pacific and Latin America) in the pharmaceutical isolators market have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Getinge, Azbil, Skan Holding, OPTIMA (METALL+PLASTIC), Syntegon Technology and Comecer) are also presented in detail.

Key Target Audience

  • Pharmaceutical Isolators Manufacturers
  • Raw Material Suppliers
  • End Users (R&D institutes and manufacturing firms)
  • Investment Companies
  • Government Bodies & Regulating Authorities
Frequently Asked Questions about the Global Pharmaceutical Isolators Market

What is the estimated value of the Global Pharmaceutical Isolators Market?

The Global Pharmaceutical Isolators Market was estimated to be valued at $1.58 Billion in 2022.

What is the growth rate of the Global Pharmaceutical Isolators Market?

The growth rate of the Global Pharmaceutical Isolators Market is 11.2%, with an estimated value of $2.42 Billion by 2026.

What is the forecasted size of the Global Pharmaceutical Isolators Market?

The Global Pharmaceutical Isolators Market is estimated to be worth $2.42 Billion by 2026.

Who are the key companies in the Global Pharmaceutical Isolators Market?

Key companies in the Global Pharmaceutical Isolators Market include Getinge, Azbil, Skan Holding, OPTIMA (METALL+PLASTIC) and Comecer.

Table of Contents

1. Market Overview
1.1 Introduction
1.2 Major Purpose of Pharmaceutical Isolators
1.3 Types of Pharmaceutical Isolators
1.4 Comparison Between Isolators and RABs
1.5 Arrangement of an Isolator Facility
2. Impact of COVID-19
2.1 Surge in Vaccine Funding
2.2 Growth in FDA Approval for Biologics
2.3 Sterile Drug Product Manufacturing during COVID-19
3. Global Market Analysis
3.1 Global Pharmaceutical Isolator Market by Value
3.2 Global Pharmaceutical Isolator Market Forecast by Value
3.3 Global Pharmaceutical Isolator Market by Tier
3.3.1 Global High-value Isolators Market by Value
3.3.2 Global High-value Isolators Market Forecast by Value
3.3.3 Global High-value Isolators Market by Tier
3.3.4 Global Premium High-value Isolators Market by Value
3.3.5 Global Premium High-value Isolators Market Forecast by Value
3.3.6 Global Mid-tier High-value Isolators Market by Value
3.3.7 Global Mid-tier High-value Isolators Market Forecast by Value
3.3.8 Global Low-value Isolators Market by Value
3.3.9 Global Low-value Isolators Market Forecast by Value
3.4 Global Pharmaceutical Isolator Market by Region
4. Regional Market Analysis
4.1 The U.S.
4.1.1 The U.S. Pharmaceutical Isolator Market by Value
4.1.2 The U.S. Pharmaceutical Isolator Market Forecast by Value
4.2 Europe
4.2.1 Europe Pharmaceutical Isolator Market by Value
4.2.2 Europe Pharmaceutical Isolator Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific Pharmaceutical Isolator Market by Value
4.3.2 Asia Pacific Pharmaceutical Isolator Market Forecast by Value
4.4 Latin America
4.4.1 Latin America Pharmaceutical Isolator Market by Value
4.4.2 Latin America Pharmaceutical Isolator Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Expansion of Biotechnology Industry
5.1.2 Explosive Growth of Cell & Gene Therapies in Development
5.1.3 Increase in Use of High-potency Active Pharmaceutical Ingredients
5.1.4 Rising Focus on Contract Development Manufacturing Organizations (CDMOs)
5.1.5 Regulatory Framework to Support Adoption of Pharmaceutical Isolators
5.2 Key Trends & Developments
5.2.1 Growing Share of Isolators in Aseptic Manufacturing Market
5.2.2 Upsurge in Pharmaceutical R&D Spending
5.2.3 Automation Inside Isolators
5.3 Challenges
5.3.1 Maintenance of Pharmaceutical Isolators
6. Competitive Landscape
6.1 Global Market
6.1.1 Key Players - Revenue Comparison
6.1.2 Key Players - Market Capitalization Comparison
6.1.3 Global High-value Isolators Market Share by Company
6.1.4 Global Premium Isolators Market Share by Company
7. Company Profiles
7.1 Getinge
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Azbil
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Skan Holding
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 OPTIMA (METALL+PLASTIC)
7.4.1 Business Overview
7.4.2 Business Strategies
7.5 Syntegon Technology
7.5.1 Business Overview
7.5.2 Business Strategies
7.6 Comecer
7.6.1 Business Overview
7.6.2 Business Strategies
List of Figures
  • Arrangement of an Isolator Facility
  • FDA Approvals for Biologics in the U.S. (2019-2020)
  • Global Pharmaceutical Isolator Market by Value (2017-2021)
  • Global Pharmaceutical Isolator Market Forecast by Value (2022-2026)
  • Global Pharmaceutical Isolator Market by Tier (2021)
  • Global High-value Isolators Market by Value (2017-2021)
  • Global High-value Isolators Market Forecast by Value (2022-2026)
  • Global High-value Isolators Market by Tier (2021)
  • Global Premium High-value Isolators Market by Value (2017-2021)
  • Global Premium High-value Isolators Market Forecast by Value (2022-2026)
  • Global Mid-tier High-value Isolators Market by Value (2017-2021)
  • Global Mid-tier High-value Isolators Market Forecast by Value (2022-2026)
  • Global Low-value Isolators Market by Value (2017-2021)
  • Global Low-value Isolators Market Forecast by Value (2022-2026)
  • Global Isolator Market by Region (2021)
  • The U.S. Pharmaceutical Isolator Market by Value (2017-2021)
  • The U.S. Pharmaceutical Isolator Market Forecast by Value (2022-2026)
  • Europe Pharmaceutical Isolator Market by Value (2017-2021)
  • Figure 4.4: Europe Pharmaceutical Isolator Market Forecast by Value (2022-2026)
  • Asia Pacific Pharmaceutical Isolator Market by Value (2017-2021)
  • Asia Pacific Pharmaceutical Isolator Market Forecast by Value (2022-2026)
  • Latin America Pharmaceutical Isolator Market by Value (2017-2021)
  • Latin America Pharmaceutical Isolator Market Forecast by Value (2022-2026)
  • Global Biotechnology Market Share by Country (2021)
  • Number of Cell & Gene Projects in Development Worldwide (2017-2021)
  • Global High-potency Active Pharmaceutical Ingredients (2017-2021)
  • Global Contract Development Manufacturing Organizations (CDMOs) Sales (2020-2025)
  • Share of Isolators in Aseptic Manufacturing Market (2015-2025)
  • Global Pharmaceutical R&D Spending (2021-2026)
  • Global High-value Isolators Market Share by Company (2021)
  • Global Premium Isolators Market Share by Company (2021)
  • Getinge Net Sales and Net Profit (Loss) (2017-2021)
  • Getinge Net Sales by Segment (2021)
  • Getinge Net Sales by Region (2021)
  • Azbil Net Sales and Net Income (2017-2021)
  • Azbil Net Sales by Segment (2021)
  • Azbil Net Sales by Region (2021)
  • Skan Holding Net Sales and Profit (2017-2021)
  • Skan Holding Net Sales by Segment (2021)
  • Skan Holding Net Sales by Region (2021)
List of Tables
  • Types of Pharmaceutical Isolators
  • Summary of Deep Renovation Activities and Products
  • COVID-19 Vaccine R&D Funding by Top Countries
  • Key Players - Revenue Comparison (2021)
  • Key Players - Market Capitalization Comparison (2022)

Companies Mentioned

  • Getinge
  • Azbil
  • Skan Holding
  • OPTIMA (METALL+PLASTIC)
  • Syntegon Technology
  • Comecer